Article
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation
16 Feb 2023
Abstract excerpt
Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective therapy for hematologic malignancies. During hematopoiesis reconstitution, the dynamic interactions between the graft’s immune cells and the recipient’s tissues lead to alloreactivity, which can be associated with the positive graft-versus-tumor effect but can also lead to a severe complication like graft-versus-host disease (GVHD). Early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
